Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Lovely late trade reported :-)
Oh, and on the Cannorcord piece - if it is their final 3% (The 3.2m shares today) - who has bought them??????
@Redolive
To change the ownership structure something has to give. At the starts of December there was barely 6m shares in circulation
I dont quite know exactly waht is going on - but I'm very sure that these disposals are not just standards sells.
I see a 3.2m shares transacted today in two lumps - Thats 3% of the company.
It could be the last of Cannacord or it could be purchses by a potential suitor - particularly given it adds up close to 3%
Exciting times
Don't be a dikk @Pumpky
I don't post things that I do not believe
FDA has committed to providing a scheduled date for 90 percent of post-CRL clarification teleconferences within 14 calendar days of a written request.
However, on further investigation. The CRL (Complete Response Letter) is actually the letter that the FDA sent to Hemo to explain their decision and feedback from the original review.
So - I retract, Vlad probably does not know yet. He will get a call anytime in the 30 days
By now, Vlad almost certainly will know the date on which the FDA will communciate their feedback
I'll get str8 to the point, this board already has my views on XP Factory :-)
There appears to be a very big spread right now - the Bid and Ask are often well beyond what you actually pay or get paid for a share. The genuine spread is also very large; yesterday was 0.75p which is 5% - this is very high.
The above leads me to think that there is a Big order being filled; low did to attract sellers, high Ask to dissuade buyers.
AIMO, DYOR
RedOlive - Be careful, I do not believe your last statemnet is factual
It's impossible to tell what is a buy and what is a sell - regardless of the price
We know from the 8.3 a few weeks ago that there was a big 1m purchase at 11p - so if any orders are being filled they could well be around that price.
Its all smoke and mirrors
Lets not get into a conversation about HemoTruth
Hemogenyx are on the cusp of something very special - lets stick to talking about the company
I happen to beleive that Hemotruth probably does have a decent holding; but I also beleive he trades the share regularly, perhaps with shares in a different pot. He's been here for years; I do with he was a put more positive at times, but ultimately that is his prerogative. My only regret is his relunctance to 'connect,' I'd welcome a quick call with him from time to time - and he also blocked me from Twitter becuase we differ in approach of how to engage the company.
So - back to business
I never expected the FDA news to come this week - it felt a little too soon. However, I do think that next week represents a very realistic prospect of getting news - The FDA are not starting from scratch, the team reviewing the IND have already reviewed the first draft AND approved in principle the plan that Hemo proposed to clear the Clincial Hold.
Come on 1st Feb :-)
Very doubtful - I tried a dummy sell and only offer 11.6ish
They only seem to be involved in a a small amount
The selling to support the buying normally seems to come from cannacord
UNtil recently 93-94% shares were not in public circulation - they sat with Private Equity, Founders, EMployyed Trust and IIs
There is probably now c10-12% that is in public hands
No cobblerman - each day we get a read out on Shore Capitals's activity (Form 8.5) . It is minimal every day
There was no form 8.3 yesterday so Cannacord did not get involved on Tuesday.
Very few went few Shore yesterday....
Trades at 8:53 / 8:54....
Cannacord to the MMs rescue???
This appears to have changed gear....
Could be an interesting few days ahead
Well done NewBoy
I've bought lots at sub 15p too :-)
I'm back in ladies and gentlemen
I never expected it to go sub 1.5p (the placing price)
So I'd be silly not to take some at these prices.
GLA, DYOR
Volume picking up - hopefully we exceed the recent daily avg of 13m
Dhton - I dont have a huge amount to say about the rest.
For me, the CEO/CFO partneship is th ekey one for a business.
I would say that the leadership team looks a big big for a small company - I think for the new owners, the easy win would be to combine "customer, commercial and marketing" into a single directorate
And maybe look to combine 1 or 2 of the other roles - I'd aim for a leadership team of 5 heads
I'm happy they have the opportunity to buy back some of the Franchise venues - they have proved how well they operate them directly. This will be help fuel growth
It's healthy and uderstandable to look for cracks, esp when the SP is not performing the way you want it to.
However, I could not be more confident that this company will continue to grow, it will get increasingly profitable as it finds way to extract more revenue from existing venues. SIte EBITDA margins are in line with expectations - and they will include the majority of staff costs impacted by living wage increases.
I just wonder if this company is maybe doing too well? I've said a number of times on here that at this mCAp it would make a wonderful acquisition for Private Equity. That may explain the SP movement - you usually see share price suppressed ahead of a take-over
I could not have more of a different opinion Simon
It's almost irrelevent whether they make a profit of £2m or a loss of £1m. Net rpfoit is a very complex metric that in recent years has been signifcantly impacted by new accounting principles
This is a company that is growing rapidly; whilst it is growing it is constantly learning and making changes to increase gross margin whcih will drive profitability.
What will drive this business is Cashflow, Revenue Growth and EBITDA Growth.
Its pretty much debt free (a few small vendor loans but nothing significant)
Its generating cash
Its growing rapidly
Its not reliant on Consumar Spending; it has a great B2B revenue stream and they are looking to grow it with a number of new appointments